Veristat
Veristat is a contract research organization that provides clinical development, regulatory, and biometrics services to pharmaceutical, biotechnology, and medical device companies. It supports clients from early-phase clinical strategy and trial design through regulatory submissions and post-approval studies, with particular expertise in complex and rare disease programs. The company generates revenue through fee-for-service and project-based contracts for outsourced clinical research and consulting services.
- IT Consulting & Implementation
- Revenue
- $180.0M
- Employees
- 900
- Founded
- 1994
- Headquarters
- Marlborough, United States of America
What 24 Arbolus experts think of Veristat
Customer sentiment is mixed: NPS is -20, despite 85% of respondents reporting more than one year of implementation. Renewal intent is uncertain or unreported for most respondents.
Who reviewed Veristat
- C-Suite 50% (12)
- Director 46% (11)
- Manager 4% (1)
Employer names and spend open once the report publishes.
Tell us when the Veristat report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
-4 Net Promoter Score, from 24 scored reviews- Promoters 6
- Passives 11
- Detractors 7
Cumulative NPS by month
+1 over 4 months- Dec 6
- Jan 6
- Sep 7
- Oct 7
Net Promoter Score across 1 reviews, accumulated up to each month. Category median -4 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 36%Plan to renew, by seniority
- 25% 8 answers
- 50% 6 answers
- 8.4/10 Average score from customers who will renew
- 5.8/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
For people who use Veristat
Do you use Veristat at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 24 customers of Veristat have already contributed
Takes a few minutes. Your identity stays anonymous.